Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Cristina Rebordosa, Estel Plana, Annalisa Rubino, Jaume Aguado, David Martinez, Alejhandra Lei, Sami Daoud, Nuria Saigi-Morgui, Susana Perez-Gutthann & Elena Rivero-Ferrer. (2022) Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1715-1733.
Read now
Read now
Cristina Rebordosa, Estel Plana, Annalisa Rubino, Jaume Aguado, Alejhandra Lei, Sami Daoud, Nuria Saigi-Morgui, Susana Perez-Gutthann & Elena Rivero-Ferrer. (2021) A Cohort Study to Evaluate the Risk of Hospitalisation for Congestive Heart Failure Associated with the Use of Aclidinium and Other Chronic Obstructive Pulmonary Disease Medications in the UK Clinical Practice Research Datalink. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1461-1475.
Read now
Read now
Ming-Chen Chan, Ching-Heng Lin & Yu Ru Kou. (2016) Hyperlipidemia in COPD is associated with decreased incidence of pneumonia and mortality: a nationwide health insurance data-based retrospective cohort study. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 1053-1059.
Read now
Read now
DP Tashkin. (2015) The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Safety 14:11, pages 1759-1772.
Read now
Read now
Mayank Ajmera, Chan Shen, Xiaoyun Pan, Patricia A Findley, George Rust & Usha Sambamoorthi. (2013) Inhaled anticholinergic use and all-cause mortality among elderly Medicare beneficiaries with chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 287-294.
Read now
Read now
Ralph J Panos. (2013) Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 221-230.
Read now
Read now
Joshiah Gordon & Ralph J Panos. (2010) Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Metabolism & Toxicology 6:3, pages 381-392.
Read now
Read now
Joseph Finkelstein, Eunme Cha & Steven M Scharf. (2009) Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. International Journal of Chronic Obstructive Pulmonary Disease 4, pages 337-349.
Read now
Read now
Daniel E Hilleman, Mark A Malesker, Lee E Morrow & Dan Schuller. (2009) A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 4, pages 253-263.
Read now
Read now
Articles from other publishers (32)
Muhammad Adrish & Nicola A. Hanania. (2023) Asthma and cardiovascular disease: A bidirectional association?. Respirology 28:3, pages 217-219.
Crossref
Crossref
Shishir Rao, Yikuan Li, Rema Ramakrishnan, Abdelaali Hassaine, Dexter CanoyJohn Cleland, Thomas LukasiewiczGholamreza Salimi-KhorshidiKazem Rahimi. (2022) An Explainable Transformer-Based Deep Learning Model for the Prediction of Incident Heart Failure. IEEE Journal of Biomedical and Health Informatics 26:7, pages 3362-3372.
Crossref
Crossref
Elena Villamañán, Carmen Sobrino, Cristina Bilbao, Jaime Fernández, Alicia Herrero, Myriam Calle, Dolores Alvaro, Maria Segura, Gracia Picazo, José Miguel Rodríguez, Gema Baldominos, Maria Teresa Ramirez, Yolanda Larrubia, Jesús Llorente, Alicia Martinez & Rodolfo Alvarez-Sala. (2021) Off-label use of inhaled bronchodilators in hospitalised patients in Spain: a multicentre observational study. European Journal of Hospital Pharmacy 28:e1, pages e23-e28.
Crossref
Crossref
Khizer Khalid, Jaskamal Padda, Anton Komissarov, Lanson B Colaco, Sandeep Padda, Armughan S Khan, Victor Melt Campos & Gutteridge Jean-Charles. (2021) The Coexistence of Chronic Obstructive Pulmonary Disease and Heart Failure. Cureus.
Crossref
Crossref
Kate Milne & Don D. Sin. 2020. Cardiac Considerations in Chronic Lung Disease. Cardiac Considerations in Chronic Lung Disease
229
245
.
Jun-Jun Yeh, Yu-Cih Yang, Chung Y. Hsu & Chia-Hung Kao. (2019) Effect of Bronchodilator and Steroid Use on Heart Disease and Stroke Risks in a Bronchiectasis–Chronic Obstructive Pulmonary Disease Overlap Cohort: A Propensity Score Matching Study. Frontiers in Pharmacology 10.
Crossref
Crossref
Tetyana Kendzerska, Shawn D. Aaron, Teresa To, Chris Licskai, Matthew Stanbrook, Nicholas T. Vozoris, Mary-Ellen Hogan, Wan C. Tan, Jean Bourbeau & Andrea S. Gershon. (2019) Effectiveness and Safety of Inhaled Corticosteroids in Older Individuals with Chronic Obstructive Pulmonary Disease and/or Asthma. A Population Study. Annals of the American Thoracic Society 16:10, pages 1252-1262.
Crossref
Crossref
Z. R. Aisanov, A. G. Chuchalin & E. N. Kalmanova. (2019) Chronic obstructive pulmonary disease and cardiovascular comorbidity. Kardiologiia 59:8S, pages 24-36.
Crossref
Crossref
Mario Cazzola, Paola Rogliani, Luigino Calzetta & Maria Gabriella Matera. (2019) Bronchodilators in subjects with asthma-related comorbidities. Respiratory Medicine 151, pages 43-48.
Crossref
Crossref
Damilola T. Adesanoye & Cynthia J. Willey. (2017) Does Cardiovascular Comorbidity Influence the Prescribing of Bronchodilators in Chronic Obstructive Pulmonary Disease?. Annals of Pharmacotherapy 51:10, pages 855-861.
Crossref
Crossref
Jillian G Baker & Robert G Wilcox. (2017) β-Blockers, heart disease and COPD: current controversies and uncertainties. Thorax 72:3, pages 271-276.
Crossref
Crossref
Rasmus Rørth, Emil L Fosbøl, Ulrik M Mogensen, Kasper Iversen, Martin Iversen, Henning Kelbæk, Frants Pedersen, Thomas Engstrøm, Christian Torp-Pedersen, Gunnar Gislason & Lars Køber. (2016) The importance of β2-agonists in myocardial infarction: Findings from the Eastern Danish Heart Registry. European Heart Journal: Acute Cardiovascular Care 5:8, pages 551-559.
Crossref
Crossref
Sara Roversi, Leonardo M. Fabbri, Don D. Sin, Nathaniel M. Hawkins & Alvar Agustí. (2016) Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care. American Journal of Respiratory and Critical Care Medicine 194:11, pages 1319-1336.
Crossref
Crossref
Chang-Hoon Lee, Seongmi Choi, Eun Jin Jang, Dong-Wook Kim, Ho Il Yoon, Yun Jung Kim, Jimin Kim, Jae-Joon Yim & Deog Kyeom Kim. (2016) The effects of inhaled respiratory drugs on the risk of stroke: A nested case-control study. Pulmonary Pharmacology & Therapeutics 40, pages 7-14.
Crossref
Crossref
Lies Lahousse, Katia M Verhamme, Bruno H Stricker & Guy G Brusselle. (2016) Cardiac effects of current treatments of chronic obstructive pulmonary disease. The Lancet Respiratory Medicine 4:2, pages 149-164.
Crossref
Crossref
Mitja Lainscak & Stefan D. Anker. (2015) Heart failure, chronic obstructive pulmonary disease, and asthma: numbers, facts, and challenges. ESC Heart Failure 2:3, pages 103-107.
Crossref
Crossref
Mario Malerba, Paolo Montuschi, Alessandro Radaeli & Mario Pirisi. (2015) Role of beta-blockers in patients with COPD: current perspective. Drug Discovery Today 20:1, pages 129-135.
Crossref
Crossref
Donald Banerji, Robert Fogel & Kai-Michael Beeh. (2014) Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data. Clinical Investigation 4:6, pages 511-533.
Crossref
Crossref
Luis Puente-Maestu, Myriam Calle, Ángel Ortega-González, Antonia Fuster, Cruz González, Eduardo Márquez-Martín, Pedro Jorge Marcos-Rodriguez, Carmen Calero, Juan Luis Rodríguez-Hermosa, Rosa Malo de Molina, Myriam Aburto, Patricia Sobradillo, Bernardino Alcázar & Gema Tirado-Conde. (2014) Multicentric study on the beta-blocker use and relation with exacerbations in COPD. Respiratory Medicine 108:5, pages 737-744.
Crossref
Crossref
Surya P. Bhatt & Mark T. Dransfield. (2013) Chronic obstructive pulmonary disease and cardiovascular disease. Translational Research 162:4, pages 237-251.
Crossref
Crossref
Meng-Ting Wang, Cheng-Liang Tsai, Yu-Wen Lo, Jun-Ting Liou, Wan-Ju Lee & I-Ching Lai. (2012) Risk of stroke associated with inhaled ipratropium bromide in chronic obstructive pulmonary disease: A population-based nested case–control study. International Journal of Cardiology 158:2, pages 279-284.
Crossref
Crossref
Robert J. Mentz, Mona Fiuzat, Monica Kraft, Joann Lindenfeld & Christopher M. O’Connor. (2012) Bronchodilators in Heart Failure Patients With COPD: Is It Time for a Clinical Trial?. Journal of Cardiac Failure 18:5, pages 413-422.
Crossref
Crossref
Rustem Zulkarneev, Naufal Zagidullin, Guzel Abdrahmanova, Uta C. Hoppe & Shamil Zagidullin. (2012) Ivabradine Prevents Heart Rate Acceleration in Patients with Chronic Obstructive Pulmonary Disease and Coronary Heart Disease after Salbutamol Inhalation. Pharmaceuticals 5:4, pages 398-404.
Crossref
Crossref
Mario Cazzola, Luigino Calzetta, Germano Bettoncelli, Claudio Cricelli, Francesco Romeo, Maria Gabriella Matera & Paola Rogliani. (2012) Cardiovascular disease in asthma and COPD: A population-based retrospective cross-sectional study. Respiratory Medicine 106:2, pages 249-256.
Crossref
Crossref
Nathaniel M. Hawkins, Mark C. Petrie, Michael R. MacDonald, Pardeep S. Jhund, Leonardo M. Fabbri, John Wikstrand & John J.V. McMurray. (2011) Heart Failure and Chronic Obstructive Pulmonary Disease. Journal of the American College of Cardiology 57:21, pages 2127-2138.
Crossref
Crossref
Norbert F. Voelkel, Catherine Grossman & Herman J. Bogaard. 2011. Textbook of Pulmonary Vascular Disease. Textbook of Pulmonary Vascular Disease
1189
1196
.
Stephen L. Rennyson, Jeremy M. Parker, John D. Symanski & Laszlo Littmann. (2010) Recurrent, severe, and rapidly reversible apical ballooning syndrome in status asthmaticus. Heart & Lung 39:6, pages 537-539.
Crossref
Crossref
Nathaniel M. Hawkins, Duolao Wang, Mark C. Petrie, Marc A. Pfeffer, Karl Swedberg, Christopher B. Granger, Salim Yusuf, Scott D. Solomon, Jan Östergren, Eric L. Michelson, Stuart J. Pocock, Aldo P. Maggioni & John J.V. McMurray. (2010) Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme. European Journal of Heart Failure 12:6, pages 557-565.
Crossref
Crossref
Anthony Grosso, Ian Douglas, Aroon D. Hingorani, Raymond MacAllister, Richard Hubbard & Liam Smeeth. (2009) Inhaled tiotropium bromide and risk of stroke. British Journal of Clinical Pharmacology 68:5, pages 731-736.
Crossref
Crossref
Iain Squire. (2009) Shortness of breath, prescription of bronchodilators and the risk of myocardial infarction. Journal of Hypertension 27:7, pages 1358-1359.
Crossref
Crossref
Bill Zhang, Frank de Vries, Efrosini Setakis & Tjeerd-Pieter van Staa. (2009) The pattern of risk of myocardial infarction in patients taking asthma medication: a study with the General Practice Research Database. Journal of Hypertension 27:7, pages 1485-1492.
Crossref
Crossref
Carles Sanjuás. (2009) Tolerabilidad y seguridad de los broncodilatadores en la EPOC. Archivos de Bronconeumología 45, pages 21-26.
Crossref
Crossref